SciClone Pharmaceuticals

SciClone profit up 4.3% to RMB622.7m in H1 2021

Its revenue rose 14.7% to RMB1.3b in the same period. 

SciClone profit up 4.3% to RMB622.7m in H1 2021

Its revenue rose 14.7% to RMB1.3b in the same period.Â